Johnson & Johnson Net Profit Margin 1986-2025 | JNJ
Current and historical net profit margin for Johnson & Johnson (JNJ) from 1986 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Johnson & Johnson net profit margin for the three months ending September 30, 2025 was .
| Johnson & Johnson Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2025-09-30 |
$92.15B |
$25.12B |
27.26% |
| 2025-06-30 |
$90.63B |
$22.66B |
25.00% |
| 2025-03-31 |
$89.33B |
$21.81B |
24.41% |
| 2024-12-31 |
$88.82B |
$14.07B |
15.84% |
| 2024-09-30 |
$87.70B |
$14.68B |
16.74% |
| 2024-06-30 |
$86.58B |
$38.02B |
43.91% |
| 2024-03-31 |
$85.65B |
$38.48B |
44.92% |
| 2023-12-31 |
$85.16B |
$35.15B |
41.28% |
| 2023-09-30 |
$76.31B |
$34.62B |
45.37% |
| 2023-06-30 |
$74.96B |
$13.05B |
17.42% |
| 2023-03-31 |
$77.46B |
$12.72B |
16.43% |
| 2022-12-31 |
$79.99B |
$17.94B |
22.43% |
| 2022-09-30 |
$77.21B |
$19.16B |
24.81% |
| 2022-06-30 |
$80.55B |
$18.37B |
22.80% |
| 2022-03-31 |
$79.85B |
$19.83B |
24.84% |
| 2021-12-31 |
$78.74B |
$20.88B |
26.52% |
| 2021-09-30 |
$91.45B |
$17.88B |
19.55% |
| 2021-06-30 |
$89.19B |
$17.77B |
19.92% |
| 2021-03-31 |
$84.21B |
$15.12B |
17.95% |
| 2020-12-31 |
$82.58B |
$14.71B |
17.82% |
| 2020-09-30 |
$80.86B |
$16.99B |
21.01% |
| 2020-06-30 |
$80.50B |
$15.19B |
18.86% |
| 2020-03-31 |
$82.73B |
$17.17B |
20.75% |
| 2019-12-31 |
$82.06B |
$15.12B |
18.42% |
| 2019-09-30 |
$81.71B |
$14.15B |
17.32% |
| 2019-06-30 |
$81.33B |
$16.33B |
20.08% |
| 2019-03-31 |
$81.59B |
$14.68B |
17.99% |
| 2018-12-31 |
$81.58B |
$15.30B |
18.75% |
| 2018-09-30 |
$81.38B |
$1.54B |
1.89% |
| 2018-06-30 |
$80.68B |
$1.37B |
1.70% |
| 2018-03-31 |
$78.69B |
$1.25B |
1.58% |
| 2017-12-31 |
$76.45B |
$1.30B |
1.70% |
| 2017-09-30 |
$74.36B |
$15.83B |
21.28% |
| 2017-06-30 |
$72.53B |
$16.34B |
22.52% |
| 2017-03-31 |
$72.17B |
$16.51B |
22.87% |
| 2016-12-31 |
$71.89B |
$16.54B |
23.01% |
| 2016-09-30 |
$71.60B |
$15.94B |
22.27% |
| 2016-06-30 |
$70.88B |
$15.03B |
21.20% |
| 2016-03-31 |
$70.18B |
$15.55B |
22.15% |
| 2015-12-31 |
$70.07B |
$15.41B |
21.99% |
| 2015-09-30 |
$70.52B |
$14.72B |
20.87% |
| 2015-06-30 |
$71.88B |
$16.11B |
22.41% |
| 2015-03-31 |
$73.59B |
$15.92B |
21.63% |
| 2014-12-31 |
$74.33B |
$16.32B |
21.96% |
| 2014-09-30 |
$74.43B |
$17.32B |
23.27% |
| 2014-06-30 |
$73.54B |
$15.55B |
21.15% |
| 2014-03-31 |
$71.92B |
$15.06B |
20.94% |
| 2013-12-31 |
$71.31B |
$13.83B |
19.40% |
| 2013-09-30 |
$70.52B |
$12.88B |
18.26% |
| 2013-06-30 |
$69.99B |
$12.87B |
18.38% |
| 2013-03-31 |
$68.59B |
$10.44B |
15.22% |
| 2012-12-31 |
$67.22B |
$10.85B |
16.14% |
| 2012-09-30 |
$65.92B |
$8.50B |
12.90% |
| 2012-06-30 |
$64.87B |
$8.74B |
13.47% |
| 2012-03-31 |
$65.00B |
$10.11B |
15.55% |
| 2011-12-31 |
$65.03B |
$9.67B |
14.87% |
| 2011-09-30 |
$64.42B |
$11.40B |
17.69% |
| 2011-06-30 |
$63.40B |
$11.61B |
18.32% |
| 2011-03-31 |
$62.13B |
$12.28B |
19.77% |
| 2010-12-31 |
$61.59B |
$13.33B |
21.65% |
| 2010-09-30 |
$62.49B |
$13.60B |
21.76% |
| 2010-06-30 |
$62.59B |
$13.53B |
21.61% |
| 2010-03-31 |
$62.50B |
$13.29B |
21.26% |
| 2009-12-31 |
$61.90B |
$12.27B |
19.82% |
| 2009-09-30 |
$60.53B |
$12.77B |
21.10% |
| 2009-06-30 |
$61.37B |
$12.74B |
20.76% |
| 2009-03-31 |
$62.58B |
$12.86B |
20.55% |
| 2008-12-31 |
$63.75B |
$12.95B |
20.31% |
| 2008-09-30 |
$64.52B |
$12.61B |
19.54% |
| 2008-06-30 |
$63.57B |
$11.85B |
18.64% |
| 2008-03-31 |
$62.25B |
$11.60B |
18.64% |
| 2007-12-31 |
$61.10B |
$10.58B |
17.31% |
| 2007-09-30 |
$58.82B |
$10.37B |
17.63% |
| 2007-06-30 |
$57.14B |
$10.58B |
18.52% |
| 2007-03-31 |
$55.37B |
$10.32B |
18.64% |
| 2006-12-31 |
$53.32B |
$11.05B |
20.73% |
| 2006-09-30 |
$52.25B |
$10.98B |
21.01% |
| 2006-06-30 |
$51.28B |
$10.76B |
20.98% |
| 2006-03-31 |
$50.67B |
$10.53B |
20.77% |
| 2005-12-31 |
$50.51B |
$10.06B |
19.92% |
| 2005-09-30 |
$50.66B |
$8.85B |
17.48% |
| 2005-06-30 |
$49.90B |
$8.66B |
17.35% |
| 2005-03-31 |
$48.62B |
$8.53B |
17.54% |
| 2004-12-31 |
$47.35B |
$8.18B |
17.28% |
| 2004-09-30 |
$45.85B |
$9.14B |
19.93% |
| 2004-06-30 |
$44.75B |
$8.87B |
19.82% |
| 2004-03-31 |
$43.60B |
$7.62B |
17.48% |
| 2003-12-31 |
$41.86B |
$7.20B |
17.19% |
| 2003-09-30 |
$40.01B |
$6.74B |
16.84% |
| 2003-06-30 |
$38.64B |
$6.39B |
16.54% |
| 2003-03-31 |
$37.38B |
$6.83B |
18.28% |
| 2002-12-31 |
$36.30B |
$6.60B |
18.17% |
| 2002-09-30 |
$35.12B |
$6.32B |
17.99% |
| 2002-06-30 |
$34.10B |
$6.12B |
17.95% |
| 2002-03-31 |
$33.21B |
$5.95B |
17.92% |
| 2001-12-31 |
$32.32B |
$5.67B |
17.54% |
| 2001-09-30 |
$31.20B |
$5.45B |
17.48% |
| 2001-06-30 |
$30.58B |
$5.25B |
17.16% |
| 2001-03-31 |
$30.07B |
$5.13B |
17.06% |
| 2000-12-31 |
$29.54B |
$4.89B |
16.56% |
| 2000-09-30 |
$29.30B |
$4.75B |
16.22% |
| 2000-06-30 |
$28.75B |
$4.54B |
15.80% |
| 2000-03-31 |
$28.05B |
$4.34B |
15.48% |
| 1999-12-31 |
$27.47B |
$4.17B |
15.17% |
| 1999-09-30 |
$27.06B |
$3.52B |
12.99% |
| 1999-06-30 |
$25.99B |
$3.37B |
12.96% |
| 1999-03-31 |
$24.89B |
$3.22B |
12.94% |
| 1998-12-31 |
$24.00B |
$3.00B |
12.52% |
| 1998-09-30 |
$23.16B |
$3.53B |
15.25% |
| 1998-06-30 |
$22.93B |
$3.42B |
14.92% |
| 1998-03-31 |
$22.75B |
$3.31B |
14.56% |
| 1997-12-31 |
$22.63B |
$3.30B |
14.60% |
| 1997-09-30 |
$22.50B |
$3.23B |
14.35% |
| 1997-06-30 |
$22.32B |
$3.12B |
14.00% |
| 1997-03-31 |
$22.00B |
$3.01B |
13.66% |
| 1996-12-31 |
$21.62B |
$2.89B |
13.35% |
| 1996-09-30 |
$20.96B |
$2.80B |
13.34% |
| 1996-06-30 |
$20.30B |
$2.67B |
13.15% |
| 1996-03-31 |
$19.68B |
$2.54B |
12.90% |
| 1995-12-31 |
$18.84B |
$2.40B |
12.75% |
| 1995-09-30 |
$18.09B |
$2.32B |
12.81% |
| 1995-06-30 |
$17.39B |
$2.22B |
12.76% |
| 1995-03-31 |
$16.54B |
$2.12B |
12.79% |
| 1994-12-31 |
$14.97B |
$2.01B |
13.40% |
| 1994-09-30 |
$14.41B |
$1.96B |
13.62% |
| 1994-06-30 |
$13.88B |
$1.89B |
13.63% |
| 1994-03-31 |
$13.51B |
$1.83B |
13.53% |
| 1993-12-31 |
$14.14B |
$1.79B |
12.64% |
| 1993-09-30 |
$14.11B |
$1.76B |
12.47% |
| 1993-06-30 |
$14.08B |
$1.72B |
12.21% |
| 1993-03-31 |
$13.96B |
$1.68B |
12.01% |
| 1992-12-31 |
$13.75B |
$1.65B |
11.99% |
| 1992-09-30 |
$13.40B |
$1.62B |
12.06% |
| 1992-06-30 |
$13.04B |
$1.57B |
12.00% |
| 1992-03-31 |
$12.66B |
$1.52B |
12.00% |
| 1991-12-31 |
$12.45B |
$1.46B |
11.74% |
| 1991-09-30 |
$12.00B |
$1.42B |
11.83% |
| 1991-06-30 |
$11.75B |
$1.37B |
11.66% |
| 1991-03-31 |
$11.54B |
$1.32B |
11.41% |
| 1990-12-31 |
$11.23B |
$1.14B |
10.18% |
| 1990-09-30 |
$11.00B |
$1.11B |
10.12% |
| 1990-06-30 |
$10.59B |
$1.07B |
10.06% |
| 1990-03-31 |
$10.15B |
$1.01B |
9.94% |
| 1989-12-31 |
$9.76B |
$1.08B |
11.09% |
| 1989-09-30 |
$9.49B |
$1.06B |
11.21% |
| 1989-06-30 |
$9.23B |
$1.04B |
11.24% |
| 1989-03-31 |
$9.13B |
$1.01B |
11.08% |
| 1988-12-31 |
$9.00B |
$0.97B |
10.82% |
| 1988-09-30 |
$8.73B |
$0.95B |
10.91% |
| 1988-06-30 |
$8.57B |
$0.92B |
10.77% |
| 1988-03-31 |
$8.34B |
$0.88B |
10.50% |
| 1987-12-31 |
$8.01B |
$0.83B |
10.40% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$450.090B |
$94.943B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
